Cerezyme 400 U, poudre pour solution à diluer pour perfusion - Durchstechflasche(n) Swissmedic Key 54663021 Registration Holder Sanofi-Aventis (Suisse) SA Name Cerezyme 400 U, poudre pour solution à diluer pour perfusion Date of registration 01.03.1999 Introduction of Sequence 11.07.2000 ATC-Classification Imiglucerase (A16AB02) Revision date 23.11.2004 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.14. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.14. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 1511.85 Limitation No Deductible 10 % Consumer price 1660.65 Feedback FB GTIN 7680546630218 Medication Code Biotechnologika Pharmacode 2843122 Disponibility
Composition imiglucerasum 400 U., mannitolum, natrii citras dihydricus corresp. natrium 38 mg, acidum citricum monohydricum, polysorbatum 80 pro vitro. Packungsbestandteile Galenic Form poudre pour solution à diluer pour perfusion Excipiens Active Agent Dose Imiglucerase 400 U
BAG: Active Agent Dose Imiglucerase 400 U
Inactive agents Citric Acid Monohydrate Mannitol Natrii Citras Dihydricus Polysorbatum 80
Source Data was imported : 04.12.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
